Skint1 inhibitors are a class of chemical compounds that specifically target and block the activity of the Skint1 protein, a member of the *Skint* family of immunoglobulin-like proteins. Skint1 is predominantly expressed in epithelial tissues and is known to play a significant role in immune cell regulation, particularly in its interaction with γδ T cells, which are a unique subset of immune cells involved in epithelial tissue homeostasis and immune surveillance. Skint1 is thought to influence the development and activation of these cells, guiding their responses to environmental signals in epithelial tissues. Inhibitors of Skint1 are designed to bind to critical regions of the protein, preventing its ability to engage in necessary molecular interactions or signaling pathways. This inhibition can disrupt Skint1's role in regulating immune cell activity and communication within epithelial layers.
The development of Skint1 inhibitors involves a detailed investigation of the protein's structure and its binding interactions with other cellular components. Techniques such as molecular modeling, X-ray crystallography, and computational docking are used to identify key binding domains within the Skint1 protein. Once these domains are characterized, chemical compounds are designed to fit these specific sites, effectively blocking Skint1's function without affecting other proteins in the *Skint* family or unrelated proteins. These inhibitors are evaluated through biochemical assays to measure their binding affinity, specificity, and overall effectiveness in inhibiting Skint1 activity. By studying Skint1 inhibitors, researchers can gain insights into the precise role Skint1 plays in immune regulation and epithelial integrity, helping to illuminate the broader function of the *Skint* family in immune system modulation and cellular communication in barrier tissues. The inhibition of Skint1 provides valuable clues about the regulatory mechanisms that maintain the balance between immune activity and tissue maintenance in epithelial environments.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporine A inhibits calcineurin, affecting T cell activation. Indirect inhibition of Skint1 may occur by altering T cell signaling pathways, which are crucial for intraepithelial T cell maintenance, a process associated with Skint1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, impacting cell growth and proliferation. Its effect on T cell function and proliferation can indirectly inhibit Skint1 by modifying the cellular context essential for intraepithelial T cell maintenance. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $199.00 $173.00 $342.00 $495.00 $690.00 | 1 | |
Azathioprine, an immunosuppressant inhibiting purine synthesis, affects lymphocyte proliferation. This can lead to an indirect inhibition of Skint1 by diminishing T cell interactions crucial for its function. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $32.00 $75.00 $118.00 | 14 | |
FTY720 sequesters lymphocytes, reducing their interaction with Skint1. This may indirectly inhibit Skint1's role in intraepithelial T cell maintenance. | ||||||
Mycophenolate mofetil | 128794-94-5 | sc-200971 sc-200971A | 20 mg 100 mg | $36.00 $107.00 | 1 | |
Inhibiting inosine monophosphate dehydrogenase, Mycophenolate Mofetil suppresses T cell proliferation, potentially affecting Skint1's function in T cell maintenance. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, affecting lymphocyte proliferation. Indirect inhibition of Skint1 could result from reduced T cell proliferation. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
Similar to Cyclosporine A, FK-506 inhibits calcineurin, affecting T cell activation. This can indirectly inhibit Skint1 by altering T cell signaling pathways. | ||||||
Corticosterone | 50-22-6 | sc-300391 sc-300391A | 100 mg 500 mg | $57.00 $108.00 | 2 | |
Corticosterone suppresses immune responses, potentially reducing Skint1's efficacy in T cell maintenance by inhibiting immune activation. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $81.00 | 5 | |
Inhibiting dihydroorotate dehydrogenase, Leflunomide impacts T cell proliferation, which could indirectly affect Skint1's function. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $60.00 $75.00 $125.00 $205.00 | 8 | |
Sulfasalazine, an anti-inflammatory, suppresses immune responses. This could indirectly impact Skint1's function in T cell maintenance. | ||||||